Valveclip® Transcatheter Mitral Valve Repair Study

NCT05021614 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2023-11-18

No results posted yet for this study

Summary

The purpose of this clinical trial is to evaluate the effectiveness and safety of the transcatheter mitral valve repair system in the treatment of patients with moderate or above degenerative mitral regurgitation.

Conditions

  • Mitral Regurgitation

Interventions

DEVICE

Valveclip® Transcatheter mitral valve repair

Transcatheter mitral valve repair system

Sponsors & Collaborators

  • Shanghai NewMed Medical Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • mao Chen, Chief · West China Hospital

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-24
Primary Completion
2024-06-30
Completion
2027-09-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05021614 on ClinicalTrials.gov